Updating speaker slide decks. Topic: Multiple sclerosis

Update of speaker slide decks on the topic of multiple sclerosis

A case study from our network partner Dr Martina Hänsel

#Multiple sclerosis (MS)
#Presentation
#Scientific summary

Initial situation

The best-selling drug from a leading pharmaceutical group, indicated for multiple sclerosis (MS), is being extensively studied. In particular, the pivotal Phase III trials are being continued as long-term follow-up studies. The company regularly presents the results at annual conferences, such as the European Committees for Treatment and Research in Multiple Sclerosis (ECTRIMS), the American Academy of Neurology (AAN) and the German Society of Neurology (DGN).

Task

The speaker slide decks for speakers and opinion leaders were to be updated based on current congress data.

Implementation/Results

Four slide decks on the topics of ‘B-cell depletion’, ‘safety’, ‘relapsing-remitting multiple sclerosis (RRMS)’ and ‘primary progressive multiple sclerosis (PPMS)’ have been updated with data presented at six international MS conferences between 2021 and 2023. A total of 96 slides were redesigned, and over 100 slides were updated with new data, particularly in reports on long-term and follow-up studies.

The project was carried out as external support in the area of medical direction and communication.